Succinchlorimide

Succinchlorimide

SCHEMBL17685407

Cc1cc(-c2cccc(NC(=O)C(C)(C)C)n2)no1.O=C1CCC(=O)N1Cl

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.43
MAPT P10636 4/20 0.42
ALDH1A1 P00352 3/20 0.42
LMNA P02545 2/20 0.42
CNR2 P34972 1/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
RAB9A P51151 4/20 0.37
CYP2C19 P33261 2/20 0.36
NPC1 O15118 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
ADORA1 P30542 1/20 0.36
RPS6KA3 P51812 1/20 0.35
CSNK1D P48730 1/20 0.35
CSNK1E P49674 1/20 0.35
CYP1A2 P05177 1/20 0.34
USP2 O75604 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2144361 0.88 KDM4E (0.50) KDM4EMAPTALDH1A1LMNACNR2
SCHEMBL14087963 0.67 KDM4E (0.52) KDM4EALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL921576 0.67 L3MBTL1 (0.54) KDM4ELMNAKMT2AMEN1RAB9A
SCHEMBL30485981 0.65 RAB9A (0.68) MAPTKMT2AMEN1RAB9ANPC1
SCHEMBL126159 0.65 RAB9A (0.68) MAPTKMT2AMEN1RAB9ANPC1
SCHEMBL31038670 0.64 ALDH1A1 (0.54) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL247331 0.64 ALDH1A1 (0.54) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL7478159 0.63 MAP3K5 (0.45) MAPTLMNAKMT2AMEN1RAB9A
SCHEMBL5833360 0.63 HPGD (0.50) KDM4EMAPTALDH1A1LMNAKMT2A
SCHEMBL6027438 0.62 ADORA1 (0.54) CNR2RAB9ACYP2C19SMN1; SMN2ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2344494-B1 AMINOTRIAZOLOPYRIDINES AND THEIR USE AS KINASE INHIBITORS SIGNAL PHARM LLC (US) 2016-04-20 EP disclosed